Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-25-000284
Filing Date
2025-03-12
Accepted
2025-03-12 17:33:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2800
  Complete submission text file 0001972362-25-000284.txt   4513
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Subject) CIK: 0000873303 (see all company filings)

EIN.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-14895 | Film No.: 25732981
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 215 FIRST STREET, SUITE 415 CAMBRIDGE MA 02142
Business Address
Nicaise Claude (Reporting) CIK: 0001644162 (see all company filings)

Type: 144